Health & Fitness Calculator

Tirzepatide Calculator

Convert a prescribed tirzepatide dose between mg, mL and U-100 syringe units using the exact concentration printed on the medication label.

Convert a tirzepatide dose already prescribed in milligrams into liquid volume using the concentration printed on your vial label, or verify the milligrams represented by a U-100 syringe measurement.

Important: This calculator does not determine what dose you should take. Enter only the dose and concentration shown on your prescription label or confirmed by your prescriber/pharmacist. Compounded tirzepatide concentrations vary, and FDA has reported serious dosing errors with compounded GLP-1 products.
Use the concentration printed by the dispensing pharmacy. Do not guess or copy a concentration from another person's vial.

Convert your prescribed dose

This field is not a dose selector. Use only the dose your clinician prescribed.
Choose U-100 only if the syringe package is explicitly labeled U-100 (100 units = 1 mL).
Used only for a theoretical dose-count estimate. It does not override the pharmacy's beyond-use date or sterility instructions.

Use this tirzepatide calculator only to convert a dose that has already been prescribed into a liquid measurement using the exact concentration printed on your own medication label. It can convert prescribed milligrams into milliliters, optionally show the equivalent mark on a U-100 insulin syringe, or work backward from U-100 units to verify how many milligrams that volume contains. It does not select a dose, create a titration plan, or replace instructions from your prescriber or dispensing pharmacy.

What this tirzepatide conversion tool does

The key number is the concentration of the liquid. Two vials can contain tirzepatide but have very different concentrations, which means the same syringe mark can represent different milligram doses. The calculator therefore requires the concentration from your label before it can perform any conversion.

If the label already says mg/mL, enter that number directly. If it says something like 20 mg / 2 mL or 5 mg / 0.5 mL, use the label-pair option and the calculator will first convert it to mg/mL.

Tirzepatide mg to mL and U-100 units formula

The arithmetic is:

Concentration (mg/mL) = medication amount in mg ÷ liquid volume in mL

Volume to administer (mL) = prescribed dose in mg ÷ concentration in mg/mL

For a syringe specifically labeled U-100, 100 units represents 1 mL of liquid, so:

U-100 units = calculated mL × 100

Units are a volume marking, not a drug dose. “25 units of tirzepatide” is incomplete information unless the concentration is also known.

Compound tirzepatide calculator safety

A compound tirzepatide calculator is most useful when a pharmacy dispenses a multi-dose liquid at a concentration that differs from another pharmacy’s product. Compounded drugs are not FDA-approved, and FDA says it has received adverse-event reports associated with compounded tirzepatide and reports of dosing errors involving compounded injectable GLP-1 products.

FDA specifically warns that patients and health professionals have sometimes measured the wrong amount, used doses beyond the approved label, dosed more frequently, or increased doses too quickly. If the prescription label, syringe, concentration, or instructions do not match what you expected, stop and contact the dispensing pharmacy or prescriber rather than trying to resolve the discrepancy by trial and error.

This calculator intentionally does not tell you how much bacteriostatic water to add, does not create reconstitution instructions, and does not calculate a self-selected titration plan.

Tirzepatide dosage for adults: current label reference

The current Zepbound prescribing information starts treatment at 2.5 mg once weekly for 4 weeks, followed by 5 mg once weekly. The dose may then be increased in 2.5 mg increments only after at least 4 weeks on the current dose. For weight reduction, the labeled maintenance doses are 5 mg, 10 mg, or 15 mg once weekly, and the maximum labeled dose is 15 mg once weekly. The 2.5 mg dose is for treatment initiation and is not an approved maintenance dose.

Mounjaro also begins at 2.5 mg once weekly and may be increased in 2.5 mg steps after at least 4 weeks when additional glycemic control is needed, with 15 mg once weekly as the adult maximum. Mounjaro is indicated for type 2 diabetes rather than weight loss. These are label references, not a recommendation that a particular person should move to the next dose.

Why this is not a weight-based dosing calculator

A tirzepatide calculator for weight loss should not choose a dose from body weight. Current Zepbound dosing uses fixed milligram dose steps selected with a clinician based on indication, response, tolerability, medical history, and the prescribing information. This page therefore does not ask for body weight to recommend a medication dose or predict how much weight someone will lose.

Example of concentration math

Suppose a prescription label says a liquid contains 20 mg in 2 mL. The concentration is:

20 mg ÷ 2 mL = 10 mg/mL

If a clinician-prescribed dose were 5 mg, the arithmetic would be:

5 mg ÷ 10 mg/mL = 0.5 mL

On a U-100 syringe, 0.5 mL corresponds to 50 units. This is an arithmetic example only; it is not an instruction to take 5 mg or 50 units.

Checking U-100 units back to milligrams

The reverse mode is useful when a written instruction includes a U-100 syringe mark and you want to verify the arithmetic against the label concentration:

mL = U-100 units ÷ 100

mg = mL × concentration in mg/mL

If the result does not match the prescription, do not “correct” the injection yourself. Ask the prescriber or pharmacy to reconcile the numbers.

Brand-name pens and single-dose devices

Brand-name Zepbound and Mounjaro devices are supplied in labeled fixed strengths. They are not meant to be converted into arbitrary insulin-syringe units with this page. Follow the Instructions for Use for the specific prescribed device.

This calculator is not a treatment safety screen

Correct measurement arithmetic does not establish that tirzepatide is appropriate or safe for a particular person. The current Zepbound prescribing information contains a boxed warning about the risk of thyroid C-cell tumors and lists a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 among its contraindications. The full prescribing information also covers gastrointestinal reactions, pancreatitis, gallbladder disease, kidney injury due to volume depletion, hypoglycemia risks with some diabetes medicines, and other precautions. Review medication-specific questions with a qualified clinician.

Frequently asked questions

Is this a tirzepatide calculator online for choosing my dose?

No. This tirzepatide calculator online performs measurement arithmetic only. Your prescribed dose must come from a licensed clinician and the medication label.

Can I use this tirzepatide calculator dosage tool for compounded medication?

Yes, only when you enter the exact concentration printed on the compounded prescription label and the exact dose already prescribed. Because compounded products can use different concentrations, do not copy another person’s concentration or syringe units.

Does this tirzepatide calculator dosage for adults tell me when to increase?

No. The page summarizes the current FDA-approved label for context, but dose escalation and maintenance selection require the prescriber to consider response and tolerability.

Is this the Fat Scientist tirzepatide calculator?

No. If you searched for fat scientist tirzepatide calculator, this is an independent Series Calculator tool. It uses the same underlying concentration arithmetic—mg, mL, and U-100 volume marks—but is not affiliated with Fat Scientist.

Can this calculator predict weight loss from tirzepatide?

No. Individual treatment response varies, and the calculator does not estimate expected pounds lost from a dose or recommend a dose for weight loss.

Methodology and sources

The calculator uses dimensional arithmetic only: prescribed mg divided by labeled mg/mL gives mL, and U-100 syringe units are mL multiplied by 100. Current Zepbound and Mounjaro prescribing information is used for the label-reference discussion and the 15 mg weekly upper limit. FDA’s current GLP-1 compounding safety page is used for the warning about unapproved compounded products and dosing errors. Calculations run locally in the browser and should be cross-checked against the prescription label and pharmacy instructions before medication is administered.